gvtcx

Transitional Drugs 6

key details

Value£12,307,059 (£14,768,471 inc. VAT)
Statuscomplete
Category (CPV) 33600000
RegionWales
Deadline8 Jan 2026
Procedureopen
SME suitableYes
OCIDocds-h6vhtk-05e923

Awards (12)

This procurement was awarded to 12 suppliers. Values shown are per-award; the notice total is £12,307,059.

SupplierValueDateStatus
Accord UK Ltd shared £1,637,728 29 Jan 2026 active
Amgen Ltd shared £1,637,728 29 Jan 2026 active
Celltrion Healthcare shared £1,637,728 29 Jan 2026 active
Dr Reddy's Laboratories (UK) Ltd shared £1,637,728 29 Jan 2026 active
Fresenius Kabi Ltd shared £1,637,728 29 Jan 2026 active
Gedeon Richter UK Ltd shared £1,637,728 29 Jan 2026 active
Organon Pharmaceuticals Ltd shared £1,637,728 29 Jan 2026 active
Samsung Bioepsis UK Ltd shared £1,637,728 29 Jan 2026 active
Sandoz Ltd shared £1,637,728 29 Jan 2026 active
Teva UK Ltd shared £1,637,728 29 Jan 2026 active
Thornton & Ross Ltd shared £1,637,728 29 Jan 2026 active
Zentiva Pharma UK Ltd shared £1,637,728 29 Jan 2026 active

description

The provision of Drugs that have recently lost exclusivity

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

4 notices published against this procurement.

PublishedTypeRegimeNotice
26 Nov 2025 Preliminary market engagement (UK2) Procurement Act 2023 077215-2025
27 Nov 2025 Tender notice (UK4) Procurement Act 2023 077818-2025
4 Feb 2026 Contract award (UK6) Procurement Act 2023 010156-2026
30 Mar 2026 Contract details (UK7) Procurement Act 2023 029286-2026

more from NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.